(Q34658945)

3 August 2017

1 reference

title

Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds (English)

1 reference

3 August 2017

0 references

1 reference

Christian Behl

1

1 reference

3 August 2017

Bernd Moosmann

series ordinal

2

1 reference

3 August 2017

publication date

1 March 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

383

1 reference

3 August 2017

issue

3-4

1 reference

3 August 2017

page(s)

521-536

1 reference

Aging, energy, and oxidative stress in neurodegenerative diseases.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Apoptosis and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

The female sex hormone oestrogen as a neuroprotectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Vitamin E protects nerve cells from amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Hydrogen peroxide mediates amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Scavestrogens protect IMR 32 cells from oxidative stress-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional Significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Apoptosis: overview and signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Reactive oxygen radicals in signaling and damage in the ischemic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Oxidative stress, glutamate, and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Intramuscular desferrioxamine in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Pathobiology of ischaemic stroke: an integrated view

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Estradiol protects against ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

beta-Amyloid protein aggregation: its implication in the physiopathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Prospects for pharmacological intervention in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Oxidants, oxidative stress and the biology of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Neuroprotective effects of estrogens: potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Proteolysis by presenilins and the renaissance of tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Antioxidants in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Beta amyloid toxicity does not require RAGE protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Signaling by reactive oxygen species in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Neurodegenerative disorders and ischemic brain diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

A radical approach to stroke therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Estrogen actions in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Secretory peptide hormones are biochemical antioxidants: structure-activity relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Neuroprotective potential of aromatic alcohols against oxidative cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Protective activity of aromatic amines and imines against oxidative nerve cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Molecular diversity of glutamate receptors and implications for brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Phenolic antioxidants: a rationale for design and evaluation of novel antioxidant drug for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Ebselen: prospective therapy for cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Apoptosis-regulating proteins as targets for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Vitamin E: protective role of a Janus molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Complement activation by beta-amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Mechanisms of neurodegenerative disorders: Part 2: control of cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Mechanisms of neuronal degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Dietary flavonoids as potential neuroprotectants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Phenothiazines as lipid peroxidation inhibitors and cytoprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Apoptosis in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

Biochemistry of Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.053

21 January 2018

Identifiers

DOI

10.1515/BC.2002.053

1 reference

3 August 2017

1 reference